Greater Iowa City, Inc. celebrates Johnson County businesses at inaugural ‘A Toast to Business’ Awards ceremony
Monday, May 5, 2025
Steven Davis, Co-Founder and CEO of Bio::Neos, Inc. —a BioVentures Center tenant—received the Youth Engagement Award.

SunHydrogen Contracts The Process Group for Front-End Engineering Design of 25 m² Renewable Hydrogen Pilot Plant
Monday, May 5, 2025
SunHydrogen has contracted The Process Group, LLC (TPG Engineers) for front-end engineering design of a >25-square-meter proof-of-concept hydrogen production pilot plant.

Innovation Challenge Awards $132,500 — S5G Therapeutics Takes Home $50,000 1st Prize
Monday, May 5, 2025
S5G Therapeutics, a startup comprised of experts in clinical and translational medicine, biomedical research, pharmaceutical sciences, and business development in the ocular therapeutics space, was awarded first place and $50,000 in the Graduate/Faculty/Staff/Incubator Startup division of Innovation Challenge.

Perspective Therapeutics Announces First Patient Dosed with PSV359 in a Phase 1/2a Study in Patients with FAP-α Positive Solid Tumors
Wednesday, April 30, 2025
Perspective Therapeutics has announced the first patient was treated with [212Pb]PSV359 in a Phase 1/2a dose-finding trial to determine safety and preliminary anti-tumor activity of the radiopharmaceutical [212Pb]PSV359 in patients with solid tumors that express fibroblast activation protein alpha (FAP-α).

Integrated DNA Technologies and Elegen Partner to Revolutionize Long DNA Synthesis Market
Tuesday, April 1, 2025
Strategic partnership between IDT and Elegen marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb

NIH funding may lead to eye drops that prevent vision loss
Wednesday, March 19, 2025
Dr. Mark Greiner and his research team, based at the Iowa Lions Eye Bank within the BioVentures Center, are using a five-year, $2.85 million grant from the National Eye Institute to develop a topical drug therapy designed to prevent vision loss caused by Fuchs endothelial corneal dystrophy.

SunHydrogen CEO Shares Update and Scale-up Plans for 1.92 m² Hydrogen Modules
Tuesday, March 11, 2025
While the world experiences volatility, our mission remains unchanged: to produce renewable hydrogen for the world at an economical price.

Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium
Saturday, January 25, 2025
Perspective Therapeutics has announced updated interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET that are being presented as a poster presentation at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO-GI) taking place January 23-25, 2025 in San Francisco, CA.

UI Center for Biocatalysis and Bioprocessing approved for Strategic Infrastructure Program grant
Wednesday, January 22, 2025
The Center for Biocatalysis and Bioprocessing (CBB) at the University of Iowa was awarded a grant of just over $1 million through the Strategic Infrastructure Grant program to expand the existing biomanufacturing infrastructure in the state.

SunHydrogen Releases Video Showcasing 1m² Green Hydrogen Panel Demonstration
Thursday, January 16, 2025
Pagination